5AY-29586-89037
2 vaccinations
1 coded response
1 check-in
1 free-text entry
0 call cases
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 020 / MA
- Registered
- 2021-08-23
- Relationship
- Self
- Race
- Other
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-04-18
Dose 1 — Pfizer-BioNTech
-
2021-05-11
Dose 2 — Pfizer-BioNTech
-
2021-08-23
Registered in v-safe
-
2021-11-11
Survey response — 6 months, dose 2MedDRA: Blood pressure increased, Delivery, Induced labour, Pre-eclampsia — Feeling: Good · Be unable to do your normal daily activitiesFree text: Preeclampsia had to be induced early. Did not have preeclampsia or elevated blood pressure with previous 2 pregnancies. Blood pressure continued to be elevated for 2 weeks after delivery.MedDRA releases: 2024-11 · check-in free text available
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-04-18 | Pfizer-BioNTech | No |
| 2 | 2021-05-11 | Pfizer-BioNTech | No |
Free text
Release 10 — 6 months, dose 2
Symptoms: Preeclampsia had to be induced early. Did not have preeclampsia or elevated blood pressure with previous 2 pregnancies. Blood pressure continued to be elevated for 2 weeks after delivery.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Blood pressure increased | · | · | ✓ |
| SD | Delivery | · | · | ✓ |
| SD | Induced labour | · | · | ✓ |
| SD | Pre-eclampsia | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release